Kuss I - Search Results

1

Imbalance in absolute counts of T lymphocyte subsets in patients with head and neck cancer and its relation to disease.

Kuss I, Hathaway B, Ferris RL, Gooding W, Whiteside TL. Kuss I, et al. Adv Otorhinolaryngol. 2005;62:161-72. doi: 10.1159/000082506. Adv Otorhinolaryngol. 2005. PMID: 15608426

2

Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck.

Kuss I, Hathaway B, Ferris RL, Gooding W, Whiteside TL. Kuss I, et al. Clin Cancer Res. 2004 Jun 1;10(11):3755-62. doi: 10.1158/1078-0432.CCR-04-0054. Clin Cancer Res. 2004. PMID: 15173082

3

Recent thymic emigrants and subsets of naive and memory T cells in the circulation of patients with head and neck cancer.

Kuss I, Schaefer C, Godfrey TE, Ferris RL, Harris JM, Gooding W, Whiteside TL. Kuss I, et al. Clin Immunol. 2005 Jul;116(1):27-36. doi: 10.1016/j.clim.2004.12.011. Clin Immunol. 2005. PMID: 15925829

4

Clinical significance of decreased zeta chain expression in peripheral blood lymphocytes of patients with head and neck cancer.

Kuss I, Saito T, Johnson JT, Whiteside TL. Kuss I, et al. Clin Cancer Res. 1999 Feb;5(2):329-34. Clin Cancer Res. 1999. PMID: 10037182

5

Spontaneous ex vivo apoptosis of peripheral blood mononuclear cells in patients with head and neck cancer.

Saito T, Kuss I, Dworacki G, Gooding W, Johnson JT, Whiteside TL. Saito T, et al. Among authors: kuss i. Clin Cancer Res. 1999 Jun;5(6):1263-73. Clin Cancer Res. 1999. PMID: 10389908

6

Effector CD8+CD45RO-CD27-T cells have signalling defects in patients with squamous cell carcinoma of the head and neck.

Kuss I, Donnenberg AD, Gooding W, Whiteside TL. Kuss I, et al. Br J Cancer. 2003 Jan 27;88(2):223-30. doi: 10.1038/sj.bjc.6600694. Br J Cancer. 2003. PMID: 12610507 Free PMC article.

7

Expression of zeta in T cells prior to interleukin-2 therapy as a predictor of response and survival in patients with ovarian carcinoma.

Kuss I, Rabinowich H, Gooding W, Edwards R, Whiteside TL. Kuss I, et al. Cancer Biother Radiopharm. 2002 Dec;17(6):631-40. doi: 10.1089/108497802320970235. Cancer Biother Radiopharm. 2002. PMID: 12537666

8

Preferential apoptosis of CD56dim natural killer cell subset in patients with cancer.

Bauernhofer T, Kuss I, Henderson B, Baum AS, Whiteside TL. Bauernhofer T, et al. Among authors: kuss i. Eur J Immunol. 2003 Jan;33(1):119-24. doi: 10.1002/immu.200390014. Eur J Immunol. 2003. PMID: 12594840 Free article.

9

Decreased zeta chain expression and apoptosis in CD3+ peripheral blood T lymphocytes of patients with melanoma.

Dworacki G, Meidenbauer N, Kuss I, Hoffmann TK, Gooding W, Lotze M, Whiteside TL. Dworacki G, et al. Among authors: kuss i. Clin Cancer Res. 2001 Mar;7(3 Suppl):947s-957s. Clin Cancer Res. 2001. PMID: 11300496

10

Role of prolactin receptor and CD25 in protection of circulating T lymphocytes from apoptosis in patients with breast cancer.

Bauernhofer T, Kuss I, Friebe-Hoffmann U, Baum AS, Dworacki G, Vonderhaar BK, Whiteside TL. Bauernhofer T, et al. Among authors: kuss i. Br J Cancer. 2003 Apr 22;88(8):1301-9. doi: 10.1038/sj.bjc.6600860. Br J Cancer. 2003. PMID: 12698200 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters